TY - JOUR
T1 - The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma
AU - Luan, Xudong
AU - Shi, Guangping
AU - Zohouri, Mahnaz
AU - Paradee, William
AU - Smith, David I.
AU - Decker, H. Jochen
AU - Cannizzaro, Linda A.
N1 - Funding Information:
This work was supported by grant VM-89 awarded by The American Cancer Society (LAC) and by grant De 356/3-2 awarded by the German Research Council (DFG, Deutsche Forschungsgemeinschaft to HJD). The authors wish to thank Dr KH Ramesh for helpful discussions.
PY - 1997
Y1 - 1997
N2 - FHIT (Fragile Histidine Triad), a putative tumor suppressor gene, was cloned from fetal brain and colon cDNA libraries. Portions of this gene are deleted in esophageal, colon, lung and breast tumors, but this gene has not been found altered in sporadic renal cell carcinomas. We report here an alternatively spliced form of this gene cloned from a kidney cDNA library. This cDNA is 1189 bp in length, and contains an additional 94 bp exon, designated exon 2a (E2a). This novel sequence is located between exon 2 and exon 3 of the FHIT gene's untranslated region and exon 2a is present in all normal kidney tissues and cell lines. Analyses performed on sporadic renal cell carcinoma (RCC) tissues and cell lines, show consistent loss of exon 8 of the FHIT cDNA in almost 60% of the cases. Interestingly, in a familial, as well as, in a metastatic RCC, derived from a patient with the sporadic form, exon 2a and exon 3 are also deleted. Northern analyses with the exon 2a of the familial and the metastatic RCC demonstrates concurrent loss of expression of a 4.4 kb transcript with the loss of the E2a sequence, suggesting that exon 2a of the FHIT gene may play an important role in the oncogenesis of renal cell carcinoma.
AB - FHIT (Fragile Histidine Triad), a putative tumor suppressor gene, was cloned from fetal brain and colon cDNA libraries. Portions of this gene are deleted in esophageal, colon, lung and breast tumors, but this gene has not been found altered in sporadic renal cell carcinomas. We report here an alternatively spliced form of this gene cloned from a kidney cDNA library. This cDNA is 1189 bp in length, and contains an additional 94 bp exon, designated exon 2a (E2a). This novel sequence is located between exon 2 and exon 3 of the FHIT gene's untranslated region and exon 2a is present in all normal kidney tissues and cell lines. Analyses performed on sporadic renal cell carcinoma (RCC) tissues and cell lines, show consistent loss of exon 8 of the FHIT cDNA in almost 60% of the cases. Interestingly, in a familial, as well as, in a metastatic RCC, derived from a patient with the sporadic form, exon 2a and exon 3 are also deleted. Northern analyses with the exon 2a of the familial and the metastatic RCC demonstrates concurrent loss of expression of a 4.4 kb transcript with the loss of the E2a sequence, suggesting that exon 2a of the FHIT gene may play an important role in the oncogenesis of renal cell carcinoma.
KW - FHIT
KW - Renal cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=0030839168&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030839168&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1201164
DO - 10.1038/sj.onc.1201164
M3 - Article
C2 - 9233780
AN - SCOPUS:0030839168
SN - 0950-9232
VL - 15
SP - 79
EP - 86
JO - Oncogene
JF - Oncogene
IS - 1
ER -